Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

The original version of this article unfortunately contained a mistake

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Interrogações sobre políticas de formação e ensino de arte nos currículos dos cursos de pedagogia

O artigo apresenta os resultados de uma pesquisa desenvolvida no programa de pós-graduação em Educação da Universidade Federal da Paraíba. A investigação objetivou analisar as contradições sociais, políticas e ideológicas presentes nos documentos institucionais sobre as políticas de formação de professores e o ensino de arte nos currículos dos cursos de Pedagogia, utilizando para tal os princípios teóricos e metodológicos da análise crítica do discurso. Foram analisadas as Diretrizes Curriculares Nacionais para o curso de Pedagogia de 2006, os projetos político-pedagógicos desses cursos nas universidades públicas da Paraíba (Universidade Federal da Paraíba - Campus João Pessoa, Universidade Federal de Campina Grande - Campus Campina Grande, Universidade Estadual da Paraíba - Campus Campina Grande) e as ementas das disciplinas relacionadas ao ensino de arte desses projetos. Apesar de as mudanças curriculares serem recentes, encontraram-se concepções e modelos descontextualizados, conservadores e equivocados no que diz respeito à formação docente e ao sentido da arte, demonstrando que existe ainda um longo caminho a ser seguido na construção de propostas curriculares que estejam comprometidas com a atividade criadora do ser humano. Portanto, investir no ensino de arte e na formação do professor-pedagogo contribuiria tanto para o enriquecimento de sua formação humana, por meio da produção artística, como para a potencialização da capacidade criadora dos estudantes, conforme proclamado pelos defensores de um ensino de arte que aponte para a multiplicidade do ser humano.The article presents the results of a study developed at the graduate program in Education of the Federal University of Paraíba. The investigation had as its objective to analyze the social, political and ideological contradictions observable in the institutional documents on the education policies for teachers and for art teaching in the curricula of Pedagogy courses, making use, for this purpose, of theoretical and methodological principles of the critical discourse analysis. The analysis included the 2006 National Curriculum Guidelines for the Pedagogy course, the political-pedagogical projects of these courses at the public universities of Paraíba (Federal University of Paraíba - João Pessoa Campus, Federal University of Campina Grande - Campina Grande Campus, State University of Paraíba - Campina Grande Campus), and the syllabuses of the disciplines related to the teaching of art in these projects. Although these curriculum changes are recent, the study found decontextualized, conservative, and mistaken conceptions and models regarding teacher education and the meaning of art, demonstrating that there is still a long way ahead in the construction of curriculum proposals committed to the creative activity of the human being. Therefore, investing in the teaching of art and in the formation of the teacher-pedagogue would contribute both to enrich their human formation through the artistic production, and to stimulate the creative capacity of the students, as proclaimed by the defenders of an art teaching that points toward the diversity of the human being

Avaliação da qualidade do cuidado hospitalar no Brasil: uma revisão sistemática

Agência Nacional de Saúde Suplementar, Rio de Janeiro, RJ, Brasil.Agência Nacional de Saúde Suplementar, Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.A avaliação da qualidade de serviços hospitalares vem ganhando importância no mundo, sendo impulsionada pela demanda de financiadores, prestadores, profissionais e pacientes. O objetivo deste estudo é revisar a literatura sobre estudos de avaliação da qualidade hospitalar no Brasil e analisar as principais abordagens, metodologias e indicadores utilizados. Foi aplicada revisão sistemática de artigos científicos, dissertações e teses com análises empíricas sobre o tema, publicados entre 1990 e 2011. Foram identificados 2.169 documentos e incluídos 62 documentos na revisão, que representam 48 estudos distintos. Predominou o uso de fontes de dados secundárias com análise das dimensões efetividade, adequação, segurança e eficiência, destacando- se a aplicação da taxa de mortalidade, taxa de adequação, taxa de eventos adversos e tempo de permanência. Métodos que controlam diferenças de risco dos pacientes foram majoritariamente aplicados. Busca-se com esta revisão contribuir apontando elementos centrais para o desenvolvimento do tema no país e para a qualificação do cuidado prestado.Quality assessment of hospital services has drawn growing international attention, driven by demand from funders, providers, practitioners, and patients. The objective of this study was to review the literature on hospital quality assessment in Brazil and analyze the main approaches, methodologies, and indicators used in the studies. The research design was a systematic literature review of scientific articles and doctoral and Master’s theses published from 1990 to 2011. The review identified 2,169 documents, and 62 were included in the review, representing 48 separate studies. Most studies used secondary data and analyzed effectiveness, adequacy, safety, and efficiency, emphasizing the application of mortality rate, adequacy rate, adverse events rate, and length of stay. Methods to control differences in patient risks were mostly applied. This review identified central elements for both the development of this theme and the improvement of hospital care in Brazil.La evaluación de la calidad de los servicios hospitalarios está recibiendo cada vez más atención internacional, dirigida por la demanda de inversores (fundadores), proveedores, profesionales y pacientes. El objetivo de este estudio es revisar la literatura de los estudios de evaluación, realizados sobre la calidad de la atención hospitalaria en Brasil, y analizar los enfoques importantes, la metodología y los indicadores aplicados. El diseño de la investigación fue una revisión sistemática de artículos científicos, de tesis de Ph.D. y de M.Sc. con análisis empírico, publicados entre 1990 y 2011. Se identificaron 2.169 documentos de los cuales se incluyeron 62 en la revisión, que representan 48 estudios separados. Principalmente, se utilizaron fuentes secundarias de datos con el análisis de las dimensiones de efectividad, adecuación, seguridad y eficiencia, enfatizando en la aplicación de las tasas de mortalidad, de adecuación y de eventos adversos, y de la duración de la estadía. Fueron aplicados métodos para controlar la diferencia en el riesgo personal de pacientes. Esta revisión señala elementos centrales con el fin de contribuir para el desarrollo del tema en el país y la mejora de la calidad de la asistencia sanitaria prestada

Life expectancy and mortality in 363 cities of Latin America

The concept of a so-called urban advantage in health ignores the possibility of heterogeneity in health outcomes across cities. Using a harmonized dataset from the SALURBAL project, we describe variability and predictors of life expectancy and proportionate mortality in 363 cities across nine Latin American countries. Life expectancy differed substantially across cities within the same country. Cause-specific mortality also varied across cities, with some causes of death (unintentional and violent injuries and deaths) showing large variation within countries, whereas other causes of death (communicable, maternal, neonatal and nutritional, cancer, cardiovascular disease and other noncommunicable diseases) varied substantially between countries. In multivariable mixed models, higher levels of education, water access and sanitation and less overcrowding were associated with longer life expectancy, a relatively lower proportion of communicable, maternal, neonatal and nutritional deaths and a higher proportion of deaths from cancer, cardiovascular disease and other noncommunicable diseases. These results highlight considerable heterogeneity in life expectancy and causes of death across cities of Latin America, revealing modifiable factors that could be amenable to urban policies aimed toward improving urban health in Latin America and more generally in other urban environments.City-level analysis of data from the SALURBAL project shows vast heterogeneity in life expectancy across cities within the same country, in addition to substantive differences in causes of death among nine Latin American countries, revealing modifiable factors that could be leveraged by municipal-level policies aimed toward improving health in urban environments